The effect of the carcinogen safrole on intracellular Ca(superscript 2+) movement in renal tubular cells has not been explored previously. The present study examined whether safrole could alter Ca(superscript 2+) handling in Madin-Darby canine kidney (MDCK) cells. Cytosolic free Ca(superscript 2+) levels ([Ca(superscript 2+)](subscript i)) in populations of cells were measured using fura-2 as a fluorescent Ca(superscript 2+) probe. Safrole at concentrations above 33 μM increased [Ca(superscript 2+)](subscript i) in a concentration-dependent manner with an EC50 value of 400 μM. The Ca(superscript 2+) signal was reduced by 90% by removing extracellular Ca(superscript 2+), but was not affected by nifedipine, verapamil, or diltiazem. Addition of Ca(superscript 2+) after safrole had depleted intracellular Ca(superscript 2+)-induced dramatic Ca(superscript 2+) influx, suggesting that safrole caused store-operated Ca(superscript 2+) entry. In Ca(superscript 2+)-free medium, after pretreatment with 650 μM safrole, 1 μM thapsigargin (an endoplasmic reticulum Ca(superscript 2+) pump inhibitor) failed to release more Ca(superscript 2+). Inhibition of phospholipase C with 2 μM U73122 did not affect safrole-induced Ca(superscript 2+) release. Trypan blue exclusion assays revealed that incubation with 650 μM safrole for 30 min did not kill cells, but killed 70% of cells after incubation for 60 min. Collectively, the data suggest that in MDCK cells, safrole induced a [Ca(superscript 2+)](subscript i) increase by causing Ca(superscript 2+) release from the endoplasmic reticulum in a phospholipase C-independent fashion, and by inducing Ca(superscript 2+) influx via store-operated Ca(superscript 2+) entry. Furthermore, safrole can cause acute toxicity to MDCK cells.